These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 34865296)

  • 1. Mitochondrial fission in allograft endothelial cells: A novel actionable target.
    Mullan CW; Pober JS
    Am J Transplant; 2022 Feb; 22(2):337-338. PubMed ID: 34865296
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulating donor mitochondrial fusion/fission delivers immunoprotective effects in cardiac transplantation.
    Tran DT; Tu Z; Alawieh A; Mulligan J; Esckilsen S; Quinn K; Sundararaj K; Wallace C; Finnegan R; Allen P; Mehrotra S; Atkinson C; Nadig SN
    Am J Transplant; 2022 Feb; 22(2):386-401. PubMed ID: 34714588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial permeability regulates cardiac endothelial cell necroptosis and cardiac allograft rejection.
    Gan I; Jiang J; Lian D; Huang X; Fuhrmann B; Liu W; Haig A; Jevnikar AM; Zhang ZX
    Am J Transplant; 2019 Mar; 19(3):686-698. PubMed ID: 30203531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The natural killer cell activating receptor, NKG2D, is critical to antibody-dependent chronic rejection in heart transplantation.
    Lin CM; Gill RG; Mehrad B
    Am J Transplant; 2021 Nov; 21(11):3550-3560. PubMed ID: 34014614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ischemia-Reperfusion Injury Enhances Lymphatic Endothelial VEGFR3 and Rejection in Cardiac Allografts.
    Dashkevich A; Raissadati A; Syrjälä SO; Zarkada G; Keränen MA; Tuuminen R; Krebs R; Anisimov A; Jeltsch M; Leppänen VM; Alitalo K; Nykänen AI; Lemström KB
    Am J Transplant; 2016 Apr; 16(4):1160-72. PubMed ID: 26689983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptomics in transplantation: More than just biomarkers of allograft rejection.
    Shah P; Valantine HA; Agbor-Enoh S
    Am J Transplant; 2021 Jun; 21(6):2000-2001. PubMed ID: 33278854
    [No Abstract]   [Full Text] [Related]  

  • 7. Macrophage subpopulations and their impact on chronic allograft rejection versus graft acceptance in a mouse heart transplant model.
    Zhao Y; Chen S; Lan P; Wu C; Dou Y; Xiao X; Zhang Z; Minze L; He X; Chen W; Li XC
    Am J Transplant; 2018 Mar; 18(3):604-616. PubMed ID: 29044999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outside-in HLA class I signaling regulates ICAM-1 clustering and endothelial cell-monocyte interactions via mTOR in transplant antibody-mediated rejection.
    Salehi S; Sosa RA; Jin YP; Kageyama S; Fishbein MC; Rozengurt E; Kupiec-Weglinski JW; Reed EF
    Am J Transplant; 2018 May; 18(5):1096-1109. PubMed ID: 29045076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement Dependence of Murine Costimulatory Blockade-Resistant Cellular Cardiac Allograft Rejection.
    Chun N; Fairchild RL; Li Y; Liu J; Zhang M; Baldwin WM; Heeger PS
    Am J Transplant; 2017 Nov; 17(11):2810-2819. PubMed ID: 28444847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating mitochondria in organ donors promote allograft rejection.
    Lin L; Xu H; Bishawi M; Feng F; Samy K; Truskey G; Barbas AS; Kirk AD; Brennan TV
    Am J Transplant; 2019 Jul; 19(7):1917-1929. PubMed ID: 30761731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B cell clonal expansion within immune infiltrates in human cardiac allograft vasculopathy.
    Moore C; Gao B; Roskin KM; Vasilescu EM; Addonizio L; Givertz MM; Madsen JC; Zorn E
    Am J Transplant; 2020 May; 20(5):1431-1438. PubMed ID: 31811777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basophils Trigger Fibroblast Activation in Cardiac Allograft Fibrosis Development.
    Schiechl G; Hermann FJ; Rodriguez Gomez M; Kutzi S; Schmidbauer K; Talke Y; Neumayer S; Goebel N; Renner K; Brühl H; Karasuyama H; Obata-Ninomiya K; Utpatel K; Evert M; Hirt SW; Geissler EK; Fichtner-Feigl S; Mack M
    Am J Transplant; 2016 Sep; 16(9):2574-88. PubMed ID: 26932231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late Failing Heart Allografts: Pathology of Cardiac Allograft Vasculopathy and Association With Antibody-Mediated Rejection.
    Loupy A; Toquet C; Rouvier P; Beuscart T; Bories MC; Varnous S; Guillemain R; Pattier S; Suberbielle C; Leprince P; Lefaucheur C; Jouven X; Bruneval P; Duong Van Huyen JP
    Am J Transplant; 2016 Jan; 16(1):111-20. PubMed ID: 26588356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of endothelial VCAM-1 expression in murine cardiac grafts. Expression of allograft endothelial VCAM-1 can be manipulated with antagonist of IFN-alpha or IL-4 and is not required for allograft rejection.
    Bergese SD; Huang EH; Pelletier RP; Widmer MB; Ferguson RM; Orosz CG
    Am J Pathol; 1995 Jul; 147(1):166-75. PubMed ID: 7541609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-induced vascular inflammation skews infiltrating macrophages to a novel remodeling phenotype in a model of transplant rejection.
    Wei X; Valenzuela NM; Rossetti M; Sosa RA; Nevarez-Mejia J; Fishbein GA; Mulder A; Dhar J; Keslar KS; Baldwin WM; Fairchild RL; Hou J; Reed EF
    Am J Transplant; 2020 Oct; 20(10):2686-2702. PubMed ID: 32320528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft-Infiltrating Macrophages Adopt an M2 Phenotype and Are Inhibited by Purinergic Receptor P2X7 Antagonist in Chronic Rejection.
    Wu C; Zhao Y; Xiao X; Fan Y; Kloc M; Liu W; Ghobrial RM; Lan P; He X; Li XC
    Am J Transplant; 2016 Sep; 16(9):2563-73. PubMed ID: 27575724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rat Cytomegalovirus Vaccine Prevents Accelerated Chronic Rejection in CMV-Naïve Recipients of Infected Donor Allograft Hearts.
    Streblow DN; Hwee YK; Kreklywich CN; Andoh T; Denton M; Smith P; Hart E; Broekel R; Pallett C; Rogers K; Streblow AD; Chuop M; Perry A; Slifka M; Messaoudi I; Orloff SL
    Am J Transplant; 2015 Jul; 15(7):1805-16. PubMed ID: 25766876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of the activating NK cell receptor NKG2D accelerates rejection of cardiac allografts.
    Fabritius C; Ritschl PV; Resch T; Roth M; Ebner S; Günther J; Mellitzer V; Nguyen AV; Pratschke J; Sauter M; Klingel K; Kotsch K
    Am J Transplant; 2017 Dec; 17(12):3199-3209. PubMed ID: 28805342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taurodeoxycholic acid and valine reverse obesity-associated augmented alloimmune responses and prolong allograft survival.
    Quante M; Iske J; Uehara H; Minami K; Nian Y; Maenosono R; Matsunaga T; Liu Y; Azuma H; Perkins D; Alegre ML; Zhou H; Elkhal A; Tullius SG
    Am J Transplant; 2022 Feb; 22(2):402-413. PubMed ID: 34551205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose IL-2 prevents murine chronic cardiac allograft rejection: Role for IL-2-induced T regulatory cells and exosomes with PD-L1 and CD73.
    Ravichandran R; Itabashi Y; Fleming T; Bansal S; Bowen S; Poulson C; Bharat A; Bremner R; Smith M; Mohanakumar T
    Am J Transplant; 2022 Sep; 22(9):2180-2194. PubMed ID: 35603986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.